These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7845878)

  • 1. [Perspectives of practical application for studies of gene p53].
    Schlichtholz B; Soussi T
    Postepy Biochem; 1994; 40(4):211-21. PubMed ID: 7845878
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K
    Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid carcinoma with anaplastic feature: association of a p53 gene mutation with anaplastic transformation.
    Tamura G; Miyoshi H; Ogata SY; Sasou S; Kudoh S; Kikuchi J; Yanagawa N; Motoyama T
    Pathol Int; 2009 Feb; 59(2):107-10. PubMed ID: 19154265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas.
    Noguchi M; Maezawa N; Nakanishi Y; Matsuno Y; Shimosato Y; Hirohashi S
    Diagn Mol Pathol; 1993 Mar; 2(1):29-35. PubMed ID: 8287223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the amplification refractory mutation allele-specific polymerase chain reaction system for sensitive and specific detection of p53 mutations in DNA.
    Low EO; Jones AM; Gibbins JR; Walker DM
    J Pathol; 2000 Mar; 190(4):512-5. PubMed ID: 10700003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human gene p53].
    Berbeć H
    Postepy Biochem; 1994; 40(1):6-11. PubMed ID: 8208639
    [No Abstract]   [Full Text] [Related]  

  • 9. The p53 network in lung carcinogenesis.
    Robles AI; Linke SP; Harris CC
    Oncogene; 2002 Oct; 21(45):6898-907. PubMed ID: 12362272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of p53 gene mutations and expressions in human colorectal tumors].
    Qian H; Yu B; Zhou X
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells.
    Horiuchi H; Kawamata H; Omotehara F; Fujii S; Fujimori T; Kuroda Y
    J Gastroenterol; 2004 Aug; 39(8):801-3. PubMed ID: 15338377
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic instability and tumor-specific DNA alterations in oral leukoplakias.
    Tanić N; Tanić N; Milasin J; Vukadinović M; Dimitrijević B
    Eur J Oral Sci; 2009 Jun; 117(3):231-7. PubMed ID: 19583749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood.
    Boman F; Peters J; Ragge N; Triche T
    Diagn Mol Pathol; 1993 Mar; 2(1):14-22. PubMed ID: 8287221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
    Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
    Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
    Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
    Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly sensitive detection method for somatic mutations in p53 gene.
    Sato T; Sato A; Ishihara H; Konishi K
    Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.